EUVIMEDOpdag EUVIMED
Vergleichsstudie

Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratio

Giulia Capelli, Giulia Lorenzoni, Maria Vittoria Chiaruttini, Paolo Delrio, Mario Guerrieri, Monica Ortenzi, Nicola Cillara, Angelo Restivo, Simona Deidda, Antonino Spinelli iD, Carmela Romano, Francesco Bianco and 21 more

Colorectal Disease · 2025

DOI: 10.1111/codi.70077 ↗

At a glance

Vergleichsstudie in Colorectal Disease, 2025. Written by Giulia Capelli and 32 co-authors. Institution: Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Padova, Italy. Major MEDLINE topics: Chemoradiotherapy, Adjuvant, Organ Sparing Treatments, Proctectomy, Rectal Neoplasms. Cited 2 times so far (Crossref); 29 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aim

The aim of this work was to apply the ‘win ratio’ to compare the outcomes of rectal‐sparing approaches [watch and wait (WW) and local excision (LE)] in the management of locally advanced rectal cancer responding to neoadjuvant chemoradiotherapy.

Method

Patients enrolled in the ReSARCh study (NCT02710812) between 2016 and 2021 were divided into two cohorts (WW vs. LE). The win ratio was calculated by dividing the number of successes (or wins) in the WW group by the number of successes in the LE group on matched pairs. Oncological outcomes (overall survival, distant and local recurrence), presence of a stoma and rectum not preserved were considered as outcomes of interest.

Results

Overall, 108 (62.1%) patients underwent LE and 66 (37.9%) WW. Patients who underwent WW were more likely to have a complete clinical response (cCR) at restaging [i.e. ycT = 0: n = 51 (80%) for WW vs. n = 45 (42%) for LE, p < 0.001]. After matching for age, sex, distance from the anal verge and T stage at restaging, i.e. ycT, 57 pairs of patients were identified. The overall win ratio considering only oncological outcomes was 0.4 (95% CI 0.02–0.94). The disadvantage of WW was mainly due to a higher rate of local recurrences. The overall win ratio considering oncological outcomes, presence of a stoma and rectum not preserved was 0.6 (95% CI 0.04–1.38), indicating a potential disadvantage for WW, but with wide confidence intervals suggesting uncertainty.

Conclusions

LE may have an advantage in terms of local recurrence rates compared with WW, potentially conferring a survival benefit. These results should be confirmed in further prospective randomized trials.

Subjects

MeSH terms (MEDLINE)

Chemoradiotherapy, AdjuvantOrgan Sparing TreatmentsProctectomyRectal NeoplasmsWatchful WaitingAdultAgedFemaleHumansMaleMiddle AgedNeoadjuvant TherapyNeoplasm Recurrence, LocalRectumTreatment Outcome

Author keywords

oncologic outcomesquality of liferectum‐sparing strategieswin ratio

Authors and institutions

  • Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG), University of Padova, Padova, Italy.
  • Department of Surgery, ASST Bergamo Est, Bergamo, Italy.
  • Unit of Biostatistics, Epidemiology and Public Health, Department of Cardiac, Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
  • Department of Colorectal Surgical Oncology, Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale, Naples, Italy.
  • Surgery Clinic, Polytechnic University, Ancona, Italy.
  • Department of Surgery, Santissima Trinità Hospital, Cagliari, Italy.

ORCID profiles: Antonino Spinelli, Dajana Glavas, Salvatore Pucciarelli

Cite

APA

Capelli, G., Lorenzoni, G., Chiaruttini, M. V., Delrio, P., Guerrieri, M., Ortenzi, M., Cillara, N., Restivo, A., Deidda, S., Spinelli, A., Romano, C., Bianco, F., Sarzo, G., Glavas, D., Morpurgo, E., Belluco, C., Palazzari, E., Chiloiro, G., Meldolesi, E., …, & Pucciarelli, S. (2025). Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratio. Colorectal Disease. https://doi.org/10.1111/codi.70077

Vancouver

Capelli G, Lorenzoni G, Chiaruttini MV, Delrio P, Guerrieri M, Ortenzi M, et al. Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratio. Colorectal Disease. 2025. doi:10.1111/codi.70077

BibTeX
@article{Capelli2025,
  author = {Capelli, Giulia and Lorenzoni, Giulia and Chiaruttini, Maria Vittoria and Delrio, Paolo and Guerrieri, Mario and Ortenzi, Monica and Cillara, Nicola and Restivo, Angelo and Deidda, Simona and Spinelli, Antonino and Romano, Carmela and Bianco, Francesco and Sarzo, Giacomo and Glavas, Dajana and Morpurgo, Emilio and Belluco, Claudio and Palazzari, Elisa and Chiloiro, Giuditta and Meldolesi, Elisa and Coco, Claudio and Pafundi, Donato Paolo and Feleppa, Cosimo and Aschele, Carlo and Bonomo, Michele and Muratore, Andrea and Mellano, Alfredo and Chiaulon, Germana and Bergamo, Francesca and Gambacorta, Maria Antonietta and Rega, Daniela and Gregori, Dario and Spolverato, Gaya and Pucciarelli, Salvatore},
  title = {Comparing local excision with watch and wait for the management of rectal cancer patients responding to neoadjuvant chemoradiotherapy: Composite endpoint analysis using the win ratio},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70077}
}
Start for free →